← All organizations

Highest phase reached

Phase 2

Last known activity

Jan 1, 2009

Defunct as of Jan 1, 2019

Timeline

2000s

  1. Jun 1, 2009

    CytoPherx— Founded

2010s

  1. Jul 30, 2018

    Immunocept— Acquired

  2. Jan 1, 2019

    CytoPherx— Defunct

Drugs by trial phase (1 distinct, 1 trials)

Phase 2 (1 own, 0 via acquisition)

Indications

Subsidiaries (1 direct, 1 total across the full acquisition tree)

Recent trials (2)

Details

Founded
Thousand Oaks, CA, US Jun 1, 2009
Last known activity
Jan 1, 2009

Notes

formerly Nephrion